Stoke Therapeutics, Inc. STOK Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s net debt?
- Stoke Therapeutics, Inc. (STOK) reported net debt of -$152.24M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s net debt changed year-over-year?
- Stoke Therapeutics, Inc.'s net debt increased by 43.4% year-over-year, from -$268.87M to -$152.24M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s net debt has grown at a -22.5% compound annual growth rate (CAGR), from -$286.16M to -$80.07M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.